Search Results

There are 38648 results for: content related to: Efficacy and safety of rilonacept (interleukin-1 trap) in patients with cryopyrin-associated periodic syndromes: Results from two sequential placebo-controlled studies

  1. Rilonacept—CAPS and Beyond

    Annals of the New York Academy of Sciences

    Volume 1182, Issue 1, December 2009, Pages: 124–134, Neil Stahl, Allen Radin and Scott Mellis

    Article first published online : 10 DEC 2009, DOI: 10.1111/j.1749-6632.2009.05074.x

  2. Safety and Pharmacokinetics of Subcutaneously Administered Rilonacept in Patients With Well-Controlled End-Stage Renal Disease (ESRD)

    The Journal of Clinical Pharmacology

    Volume 50, Issue 7, July 2010, Pages: 835–841, Dr Allen Radin, Dr Thomas Marbury, Mr Greg Osgood and Dr Pavel Belomestnov

    Article first published online : 7 MAR 2013, DOI: 10.1177/0091270009351882

  3. You have full text access to this OnlineOpen article
    Rilonacept (interleukin-1 trap) for prevention of gout flares during initiation of uric acid–lowering therapy: Results from a phase III randomized, double-blind, placebo-controlled, confirmatory efficacy study

    Arthritis Care & Research

    Volume 64, Issue 10, October 2012, Pages: 1462–1470, H. Ralph Schumacher Jr., Robert R. Evans, Kenneth G. Saag, James Clower, William Jennings, Steven P. Weinstein, George D. Yancopoulos, Jian Wang and Robert Terkeltaub

    Article first published online : 27 SEP 2012, DOI: 10.1002/acr.21690

  4. You have full text access to this OnlineOpen article
    Rilonacept (Interleukin-1 Trap) in the prevention of acute gout flares during initiation of urate-lowering therapy: Results of a phase II randomized, double-blind, placebo-controlled trial

    Arthritis & Rheumatism

    Volume 64, Issue 3, March 2012, Pages: 876–884, H. Ralph Schumacher Jr., John S. Sundy, Robert Terkeltaub, Howard R. Knapp, Scott J. Mellis, Neil Stahl, George D. Yancopoulos, Yuhwen Soo, Shirletta King-Davis, Steven P. Weinstein, Allen R. Radin and 0619 Study Group

    Article first published online : 28 FEB 2012, DOI: 10.1002/art.33412

  5. Long-Term Safety and Efficacy of Rilonacept in Patients With Systemic Juvenile Idiopathic Arthritis

    Arthritis & Rheumatism

    Volume 65, Issue 9, September 2013, Pages: 2486–2496, Daniel J. Lovell, Edward H. Giannini, Andreas O. Reiff, Yukiko Kimura, Suzanne Li, Philip J. Hashkes, Carol A. Wallace, Karen B. Onel, Dirk Foell, Richard Wu, Stephanie Biedermann, Jennifer D. Hamilton and Allen R. Radin

    Article first published online : 26 AUG 2013, DOI: 10.1002/art.38042

  6. You have full text access to this OnlineOpen article
    A pilot study to evaluate the safety and efficacy of the long-acting interleukin-1 inhibitor rilonacept (interleukin-1 trap) in patients with familial cold autoinflammatory syndrome

    Arthritis & Rheumatism

    Volume 58, Issue 8, August 2008, Pages: 2432–2442, Raphaela Goldbach-Mansky, Sharukh D. Shroff, Mildred Wilson, Christopher Snyder, Sara Plehn, Beverly Barham, Tuyet-Hang Pham, Frank Pucino, Robert A. Wesley, Joanne H. Papadopoulos, Steven P. Weinstein, Scott J. Mellis and Daniel L. Kastner

    Article first published online : 30 JUL 2008, DOI: 10.1002/art.23620

  7. You have full text access to this OnlineOpen article
    Efficacy and safety of the interleukin-1 antagonist rilonacept in Schnitzler syndrome: an open-label study

    Allergy

    Volume 67, Issue 7, July 2012, Pages: 943–950, K. Krause, K. Weller, R. Stefaniak, H. Wittkowski, S. Altrichter, F. Siebenhaar, T. Zuberbier and M. Maurer

    Article first published online : 15 MAY 2012, DOI: 10.1111/j.1398-9995.2012.02843.x

  8. Role of Interleukin-1 Inhibitors in the Management of Gout

    Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy

    Volume 33, Issue 7, July 2013, Pages: 744–753, Tran H. Tran, Jacqueline T. Pham, Hira Shafeeq, Kendra R. Manigault and Vibhuti Arya

    Article first published online : 3 APR 2013, DOI: 10.1002/phar.1265

  9. Mechanisms of uric acid crystal-mediated autoinflammation

    Immunological Reviews

    Volume 233, Issue 1, January 2010, Pages: 218–232, Fabio Martinon

    Article first published online : 23 DEC 2009, DOI: 10.1111/j.0105-2896.2009.00860.x

  10. You have full text access to this OnlineOpen article
    The emerging role of interleukin-1β in autoinflammatory diseases

    Arthritis & Rheumatism

    Volume 63, Issue 2, February 2011, Pages: 314–324, Helen J. Lachmann, Pierre Quartier, Alexander So and Philip N. Hawkins

    Article first published online : 28 JAN 2011, DOI: 10.1002/art.30105

  11. Impaired cytokine responses in patients with cryopyrin-associated periodic syndrome (CAPS)

    Clinical & Experimental Immunology

    Volume 177, Issue 3, September 2014, Pages: 720–731, M. H. Haverkamp, E. van de Vosse, R. Goldbach-Mansky and S. M. Holland

    Article first published online : 24 JUL 2014, DOI: 10.1111/cei.12361

  12. You have free access to this content
    Rilonacept and canakinumab

    British Journal of Clinical Pharmacology

    Volume 71, Issue 5, May 2011, Pages: 639–641, Eline A. Dubois, Robert Rissmann and Adam F. Cohen

    Article first published online : 11 APR 2011, DOI: 10.1111/j.1365-2125.2011.03958.x

  13. You have full text access to this OnlineOpen article
    Concordance of preclinical and clinical pharmacology and toxicology of monoclonal antibodies and fusion proteins: soluble targets

    British Journal of Pharmacology

    Volume 166, Issue 3, June 2012, Pages: 806–822, Pauline L Martin and Peter J Bugelski

    Article first published online : 8 MAY 2012, DOI: 10.1111/j.1476-5381.2011.01812.x

  14. You have free access to this content
    The NLRP3 inflammasome in health and disease: the good, the bad and the ugly

    Clinical & Experimental Immunology

    Volume 166, Issue 1, October 2011, Pages: 1–15, P. Menu and J. E. Vince

    Article first published online : 15 JUL 2011, DOI: 10.1111/j.1365-2249.2011.04440.x

  15. You have full text access to this OnlineOpen article
    ACR Meeting

    Arthritis & Rheumatism

    Volume 64, Issue S10, October 2012, Pages: S1–S1216,

    Article first published online : 11 OCT 2012, DOI: 10.1002/art.37735

  16. You have free access to this content
    Immunology in clinic review series; focus on autoinflammatory diseases: update on monogenic autoinflammatory diseases: the role of interleukin (IL)-1 and an emerging role for cytokines beyond IL-1

    Clinical & Experimental Immunology

    Volume 167, Issue 3, March 2012, Pages: 391–404, R. Goldbach-Mansky

    Article first published online : 30 JAN 2012, DOI: 10.1111/j.1365-2249.2011.04533.x

  17. You have full text access to this OnlineOpen article
    The need to compare rilonacept against active treatment for prevention of gout flares: Comment on the article by Schumacher et al

    Arthritis & Rheumatism

    Volume 64, Issue 7, July 2012, Pages: 2415–2416, Aryeh M. Abeles

    Article first published online : 26 JUN 2012, DOI: 10.1002/art.34476

  18. Blocking Interleukin-1 in Rheumatic Diseases

    Annals of the New York Academy of Sciences

    Volume 1182, Issue 1, December 2009, Pages: 111–123, Raphaela Goldbach-Mansky

    Article first published online : 10 DEC 2009, DOI: 10.1111/j.1749-6632.2009.05159.x

  19. You have full text access to this OnlineOpen article
    Interleukin-1 antagonism in acute gout: Is targeting a single cytokine the answer?

    Arthritis & Rheumatism

    Volume 62, Issue 10, October 2010, Pages: 2845–2849, Tuhina Neogi

    Article first published online : 1 JUL 2010, DOI: 10.1002/art.27635

  20. Interleukin-1 inhibition by anakinra in refractory chronic tophaceous gout

    International Journal of Rheumatic Diseases

    Volume 14, Issue 3, August 2011, Pages: e33–e37, Ai P. TRAN and Jack EDELMAN

    Article first published online : 5 AUG 2011, DOI: 10.1111/j.1756-185X.2011.01629.x